Cellectis’ Investor R&D Day 2025

October 16, 2025

On October 16, 2025, Cellectis will host an in-person R&D Day in New York City. 
 

The Company’s leadership team and key opinion leaders will present the Phase 1 dataset and outline the late-stage development strategy for lasme-cel (UCART22) in r/r B-ALL and will share insights on the Company’s vision and differentiated capabilities.

Attendance is by invitations only